Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk revealed a stunning increase in pollution amid plans to boost production of its popular weight loss drug Wegovy.

Under terms of the deal, Novo Nordisk will obtain global rights to develop, manufacture, and commercialize LX9851 for obesity and metabolic disorders. Novo Nordisk is expanding its obesity drug ...

LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries intensify that the obesity drug market ...

Pharmaceutical giant Novo Nordisk (NYSE: NVO) built its business on insulin and has emerged as a leading innovator in GLP-1 agonists, relatively new drugs that treat obesity and type 2 diabetes by ...

What just happened? German software giant SAP has overtaken Danish healthcare company Novo Nordisk to become Europe's most valuable company. SAP's stock has performed exceptionally well ...

The company now holds the exclusive rights to develop, manufacture and sell the drug in much of the world It has been approved for early trials in China and the U.S.

No­vo Nordisk is re­or­ga­niz­ing its re­search and ear­ly de­vel­op­ment unit in an ef­fort to “fu­ture-proof the or­ga­ni­za­tion” and “sig­nif­i­cant­ly in­crease ...

rather than big chunks of what we're doing that we're no longer needing.” Novo Nordisk links CagriSema to 16% weight loss, sending stock down again News on the changes came the week after ...

An attorney representing a migrant sent to El Salvador under the Alien Enemies Act says her client was deported due to a soccer logo tattoo ... to submit some background information and schedule ...

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most ...